190
Participants
Start Date
February 11, 2021
Primary Completion Date
May 14, 2023
Study Completion Date
May 14, 2023
Clonidine HCl Mucoadhesive Buccal Tablet
100 μg of clonidine per tablet
Placebo Mucoadhesive Buccal Tablet
Placebo
New York Cancer and Blood Specialists, New York
Northwell Health, New York
Hôpital Saint Joseph, Marseille
AHN Cancer Institute - Allegheny General, Pittsburgh
Mary Hillman Radiation Oncology Center at UPMC Shadyside, Pittsburgh
Hospital Clínico Universitario Santiago de Compostela, Santiago de Compostela
Thomas Jefferson University, Philadelphia
Reading Hospital, West Reading
Christiana Care Health Services, Newark
Hospital de Donostia, San Sebastián
Greater Baltimore Medical Center, Baltimore
Eastern Virginia Medical School, Norfolk
Novant Health Cancer Institute - Forsyth, Winston-Salem
University of North Carolina at Chapel Hill, Chapel Hill
CaroMont Regional Medical Center, Gastonia
Novant Health Cancer Institute, Charlotte
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda
Hospital Universitario Quirónsalud Madrid, Madrid
Charleston Oncology, Charleston
Centre Hospitalier Universitaire Morvan / Centre Hospitalier Universitaire de Brest, Brest
University Cancer & Blood Center, Athens
Hospital Complejo Universitario de Navarra, Pamplona
IACT Health (Centricity Research), Columbus
Memorial Healthcare System, Pembroke Pines
Miami Cancer Institute, Miami
Boca Raton Regional Hospital, Boca Raton
Klinikum Kassel GmbH, Kassel
Hospital Meixoeiro, Vigo
Ballad Health, Johnson City
Centre Hospitalier de Dax-Côte d'Argent, Dax
CHU de Saint Etienne, Saint-Priest-en-Jarez
Summa Health System, Akron
Mercy Health, Youngstown
University of Cincinnati Medical Center, Cincinnati
Henry Ford Health System, Detroit
Hospital Universitario Cruces de Bilbao, Barakaldo
Des Moines Oncology Research Association, Des Moines
Institut Jean Godinot, Reims
UnityPoint Health, Cedar Rapids
HSHS St. Vincent Hospital Cancer Centers at HSHS St. Vincent Hospital, Green Bay
Institut Andree Dutreix / Centre de Cancerologie Dunkerque, Coudekerque-Branche
Edward Elmhurst Health, Elmhurst
NorthShore University Health Systems, Evanston
AMITA Health, Hinsdale
Decatur Memorial Hospital, Decatur
Cox Medical Centers, Springfield
Caritas Klinikum Saarbrucken St. Theresia, Saarbrücken
East Jefferson General Hospital, Metairie
Louisiana State University Health - Shreveport, Shreveport
Willis-Knighton Cancer Center, Shreveport
University of Arkansas for Medical Sciences, Little Rock
Stephenson Cancer Center, Oklahoma City
Oklahoma Cancer Specialists, Tulsa
Universitatsklinikum Freiburg, Freiburg im Breisgau
Hendrick Cancer Center, Abilene
Centre Hospitalier Universitaire Amiens-Picardie, Amiens
Grand Valley Oncology, Grand Junction
Clinique François Chénieux, Limoges
Long Beach Memorial Medical Center, Long Beach
Pomona Valley Hospital Medical Center, Pomona
Orange Coast Memorial Medical Center, Fountain Valley
Centre hopitalier intercommunal de Créteil, Créteil
Institut Gustave Roussy, Desmoulins, Villejuif
Benaroya Research Institute at Virginia Mason, Seattle
Providence Regional Cancer Partnership, Everett
PeaceHealth, Bellingham
Summit Health, Florham Park
Rhode Island Hospital, Providence
Centre Hospitalier Universitaire La miletrie, Nice
Ponce Medical School Foundation, Ponce
Hospital Universitari Son Espases, Palma
Hospital Universitari Vall d'Hebron, Barcelona
Institut Català d'Oncologia Hospitalet (Hospital Duran i Reynals), Barcelona
Hospital Universitari Son Llàtzer, Palma de Mallorca
Lead Sponsor
Monopar Therapeutics
INDUSTRY